Healthcare provider profile · identity verified

Robin L Myers, APRN

Nurse Practitioner · BRANDON, VT · NPI 1609896604

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	486	137
Omeprazole	Omeprazole	357	96
Lisinopril	Lisinopril	276	74
Amlodipine Besylate	Amlodipine Besylate	267	80
Levothyroxine Sodium	Levothyroxine Sodium	220	59
Losartan Potassium	Losartan Potassium	217	60
Simvastatin	Simvastatin	215	55
Rosuvastatin Calcium	Rosuvastatin Calcium	195	50
Escitalopram Oxalate	Escitalopram Oxalate	171	42
Hydrochlorothiazide	Hydrochlorothiazide	167	46
Metoprolol Succinate	Metoprolol Succinate	162	40
Pantoprazole Sodium	Pantoprazole Sodium	160	56
Metformin Hcl	Metformin Hcl	158	45
Eliquis	Apixaban	145	29
Alendronate Sodium	Alendronate Sodium	140	38
Gabapentin	Gabapentin	138	27
Duloxetine Hcl	Duloxetine Hcl	128	32
Glimepiride	Glimepiride	128	34
Potassium Chloride	Potassium Chloride	98	25
Sertraline Hcl	Sertraline Hcl	97	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	92	20
Trazodone Hcl	Trazodone Hcl	89	23
Pregabalin	Pregabalin	88	13
Torsemide	Torsemide	84	23
Albuterol Sulfate Hfa	Albuterol Sulfate	83	33
Metoprolol Tartrate	Metoprolol Tartrate	73	22
Mirtazapine	Mirtazapine	67	22
Famotidine	Famotidine	66	22
Jardiance	Empagliflozin	66	18
Lorazepam	Lorazepam	61	12
Spironolactone	Spironolactone	59	19
Morphine Sulfate Er	Morphine Sulfate	55	suppressed
Pravastatin Sodium	Pravastatin Sodium	55	20
Oxycodone Hcl	Oxycodone Hcl	54	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	54	15
Atenolol	Atenolol	52	15
Bupropion Xl	Bupropion Hcl	52	15
Fluticasone Propionate	Fluticasone Propionate	52	24
Zolpidem Tartrate	Zolpidem Tartrate	52	12
Citalopram Hbr	Citalopram Hydrobromide	51	15
Januvia	Sitagliptin Phosphate	51	12
Carvedilol	Carvedilol	46	11
Tramadol Hcl	Tramadol Hcl	45	15
Prednisone	Prednisone	43	37
Humalog Kwikpen U-100	Insulin Lispro	40	suppressed
Paroxetine Hcl	Paroxetine Hcl	39	suppressed
Enalapril Maleate	Enalapril Maleate	37	suppressed
Ozempic	Semaglutide	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	32
Ezetimibe	Ezetimibe	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Furosemide	Furosemide	34	12
Montelukast Sodium	Montelukast Sodium	34	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	32	25
Ramipril	Ramipril	31	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	31	13
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Novolin N	Insulin Nph Human Isophane	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	25
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Estradiol	Estradiol	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	15
Allopurinol	Allopurinol	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	12
Acyclovir	Acyclovir	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Folic Acid	Folic Acid	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Clonazepam	Clonazepam	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Cephalexin	Cephalexin	15	11
Meloxicam	Meloxicam	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Baclofen	Baclofen	14	suppressed
Nystatin	Nystatin	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Anastrozole	Anastrozole	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Digoxin	Digoxin	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Alprazolam	Alprazolam	12	suppressed
Diazepam	Diazepam	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Finasteride	Finasteride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error